학술논문
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT
Document Type
Article
Author
Source
In Blood Advances 14 February 2023 7(3):285-292
Subject
Language
ISSN
2473-9529